{"id":7116,"date":"2020-06-22T06:03:21","date_gmt":"2020-06-22T13:03:21","guid":{"rendered":"https:\/\/2020dev.rakuten-med.com\/?p=7116"},"modified":"2022-04-19T21:26:18","modified_gmt":"2022-04-20T04:26:18","slug":"rakuten-medical-presents-data-characterizing-how-photoimmunotherapy-induces-cancer-cell-death-and-enhances-the-immune-response-preclinically","status":"publish","type":"press_releases","link":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/","title":{"rendered":"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically"},"content":{"rendered":"<p><span class=\"xn-location\">SAN MATEO, Calif.<\/span>,\u00a0<span class=\"xn-chron\">June 22, 2020<\/span>\u00a0\/PRNewswire\/ &#8212;<b>\u00a0<\/b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2837055-1&amp;h=2138806485&amp;u=https%3A%2F%2Frakuten-med.com%2F&amp;a=Rakuten+Medical%2C+Inc.\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Rakuten Medical, Inc.<\/a>\u00a0(Rakuten Medical) today announced the results of two preclinical studies presented at the American Association for Cancer Research (AACR) Virtual Meeting II.\u00a0 These studies further demonstrate the mechanism of action of Rakuten Medical&#8217;s\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2837055-1&amp;h=1946443107&amp;u=https%3A%2F%2Frakuten-med.com%2Ftechnology%2F&amp;a=Illuminox\u2122%E2%84%A2\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Illuminox\u2122<\/a>\u00a0technology platform with its antibody-IRDye<sup>\u00ae<\/sup> 700DX conjugate and how this unique technology induces tumor cells and enhances the adaptive immune response.\u00a0<a href=\"https:\/\/www.prnewswire.com\/news-releases\/rakuten-medical-presents-data-characterizing-how-photoimmunotherapy-induces-cancer-cell-death-and-enhances-the-immune-response-preclinically-301080849.html?tc=eml_cleartime\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SAN MATEO, Calif.,\u00a0June 22, 2020\u00a0\/PRNewswire\/ &#8212;\u00a0Rakuten Medical, Inc.\u00a0(Rakuten Medical) today announced the results of two preclinical studies presented at the [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"class_list":["post-7116","press_releases","type-press_releases","status-publish","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically - Rakuten Medical - To conquer cancer.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically - Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif.,\u00a0June 22, 2020\u00a0\/PRNewswire\/ &#8212;\u00a0Rakuten Medical, Inc.\u00a0(Rakuten Medical) today announced the results of two preclinical studies presented at the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/\" \/>\n<meta property=\"og:site_name\" content=\"Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-20T04:26:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2021\/02\/RakutenMedical_KV.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/06\\\/22\\\/7116\\\/\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/06\\\/22\\\/7116\\\/\",\"name\":\"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically - Rakuten Medical - To conquer cancer.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\"},\"datePublished\":\"2020-06-22T13:03:21+00:00\",\"dateModified\":\"2022-04-20T04:26:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/06\\\/22\\\/7116\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/06\\\/22\\\/7116\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2020\\\/06\\\/22\\\/7116\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\",\"name\":\"Rakuten Medical - To conquer cancer.\",\"description\":\"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically - Rakuten Medical - To conquer cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/","og_locale":"en_US","og_type":"article","og_title":"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically - Rakuten Medical - To conquer cancer.","og_description":"SAN MATEO, Calif.,\u00a0June 22, 2020\u00a0\/PRNewswire\/ &#8212;\u00a0Rakuten Medical, Inc.\u00a0(Rakuten Medical) today announced the results of two preclinical studies presented at the [&hellip;]","og_url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/","og_site_name":"Rakuten Medical - To conquer cancer.","article_modified_time":"2022-04-20T04:26:18+00:00","og_image":[{"width":1500,"height":900,"url":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2021\/02\/RakutenMedical_KV.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/","url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/","name":"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically - Rakuten Medical - To conquer cancer.","isPartOf":{"@id":"https:\/\/rakuten-med.com\/us\/#website"},"datePublished":"2020-06-22T13:03:21+00:00","dateModified":"2022-04-20T04:26:18+00:00","breadcrumb":{"@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2020\/06\/22\/7116\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rakuten-med.com\/us\/"},{"@type":"ListItem","position":2,"name":"Rakuten Medical Presents Data during AACR Characterizing how Illuminox\u2122 (an Investigational Platform based on Photoimmunotherapy) Induces Cancer Cell Death and Enhances the Immune Response Preclinically"}]},{"@type":"WebSite","@id":"https:\/\/rakuten-med.com\/us\/#website","url":"https:\/\/rakuten-med.com\/us\/","name":"Rakuten Medical - To conquer cancer.","description":"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rakuten-med.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases\/7116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/types\/press_releases"}],"author":[{"embeddable":true,"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/users\/4"}],"wp:attachment":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/media?parent=7116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}